EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Remission of refractory esophageal lichen planus induced by tofacitinib

Valentina Bieneck, Annegrit Decker iD, Annette Schmitt-Graeff iD, Wolfgang Kreisel iD, Franziska Schauer iD

Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · 1384-1388

DOI: 10.1055/a-2300-0375 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von Valentina Bieneck und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Lichen Planus, Piperidines, Pyrimidines, Pyrroles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As of now, there exists no established therapy for ELP. Retinoids, which are standard in treating cutaneous LP, do not exhibit positive effects in ELP. While topical glucocorticosteroids often yield favorable responses in esophageal inflammation, some cases prove recalcitrant or refractory. In such instances, various immunosuppressive therapies have been attempted with variable success. This report details a severe case of ELP that showed resistance to prednisolone, acitretin, alitretinoin, adalimumab, tacrolimus, hydroxychloroquine plus mycophenolate mofetil, and cyclophosphamide. The initiation of the JAK inhibitor tofacitinib induced an impressive clinical, endoscopic, and histological remission. This positive response to a JAK inhibitor is discussed in the context of our evolving understanding of the immune-mediated pathogenesis of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lichen PlanusPiperidinesPyrimidinesPyrrolesHumansEsophageal DiseasesRemission InductionTreatment Outcome

Substanzen

PiperidinesPyrimidinesPyrrolestofacitinib

Autor:innen und Institutionen

  • Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of Medicine II, Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, Medical Center, University of Freiburg, Freiburg, Germany.
  • University of Freiburg Faculty of Medicine, Freiburg, Germany.

ORCID-Profile: Annegrit Decker, Annette Schmitt-Graeff, Wolfgang Kreisel, Franziska Schauer

Zitieren

APA

Bieneck, V., Decker, A., Schmitt-Graeff, A., Kreisel, W., & Schauer, F. (2024). Remission of refractory esophageal lichen planus induced by tofacitinib. Zeitschrift für Gastroenterologie, 62(09), 1384-1388. https://doi.org/10.1055/a-2300-0375

Vancouver

Bieneck V, Decker A, Schmitt-Graeff A, Kreisel W, Schauer F. Remission of refractory esophageal lichen planus induced by tofacitinib. Zeitschrift für Gastroenterologie. 2024;62(09):1384-1388. doi:10.1055/a-2300-0375

BibTeX
@article{Bieneck2024,
  author = {Bieneck, Valentina and Decker, Annegrit and Schmitt-Graeff, Annette and Kreisel, Wolfgang and Schauer, Franziska},
  title = {Remission of refractory esophageal lichen planus induced by tofacitinib},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2024},
  volume = {62},
  number = {09},
  pages = {1384--1388},
  doi = {10.1055/a-2300-0375}
}
Kostenlos starten →